class = “cf”>
The European Union (EU) will receive 150 million additional doses of the vaccine developed by Moderna against the new type of coronavirus (Kovid-19).
The European Commission has announced that the option to take additional doses has been activated as part of the second vaccine purchase contract signed with Moderna in February.
In the statement, it was noted that as an option, Moderna will provide an additional 150 million doses of vaccine to EU member states in 2022.
On the other hand, the EU does not share information on vaccine prices on the grounds that it is a trade secret.
The EU signed the first contract with Moderna to deliver 160 million doses in November, and the second option contract in February for a total of 300 million doses.
To date, the EU, including options, will receive 2.4 billion doses of vaccine with BioNTech-Pfizer, 400 million with AstraZeneca, 300 million with Sanofi-GSK, 400 million with Johnson & Johnson, 405 million with CureVac, 460 million with Moderna have contracts.
So far, vaccines produced by the companies BioNTech-Pfizer, Moderna, AstraZeneca and Johnson & Johnson have received EU approval and are being applied.
This guide guides gastronomy enthusiasts